Literature DB >> 23053986

DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population.

Qunying Wu1, Sen Lu, Ling Wang, Jiaojiao Hu, Fengchang Qiao, Xuemei Qiu, Chengcheng Zhao, Yingbin Lao, Yunwei Song, Hong Fan.   

Abstract

DNA-methyltransferase (DNMT)-3A plays a crucial role in embryonic development and aberrant DNA methylation in carcinogenesis. Polymorphisms of the DNMT3A gene may influence its enzymatic activity and its contribution to susceptibility to cancer. This study evaluated the association of DNMT3A rs36012910 A>G with susceptibility to gastric cancer (GC) in a Chinese population. Genomic DNA was extracted from samples taken from 340 patients with GC and 251 healthy control subjects. The genotype frequency of DNMT3A rs36012910 A>G in all subjects was detected by polymerase chain reaction-restriction fragment length polymorphism and confirmed by sequencing. Stratification analyses were used to study subgroups by age and gender and to evaluate the association of rs36012910 A>G polymorphism with genetic susceptibility to GC. All patients and control individuals were successfully genotyped for the DNMT3A rs36012910 A>G polymorphism. The frequency of DNMT3A rs36012910 allele G is 3.39 % in healthy individuals and 7.78 % in GC patients, respectively. The rs36012910 AG genotype was significantly more common in the GC group than in the controls, although the rs36012910 GG genotype was only one case in GC patients. Further stratification indicated that AG+GG genotypes were associated with susceptibility to GC in males older than 60, but this polymorphism has no significant association with GC susceptibility in females. Male individuals who carried AG+GG genotypes had a 2.362-fold increased risk of GC compared to those who carried the AA genotype. The rs36012910 allele G was associated with an increased risk of GC compared to the rs36012910 allele A. This is the first report to investigate the distribution and evaluate the association of a rare SNP in DNMT3A with genetic susceptibility to GC. DNMT3A rs36012910 A>G might become a potential biomarker for use in GC prediction, although further studies in larger groups and different populations are needed for confirmation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053986     DOI: 10.1007/s11033-012-1996-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  11 in total

Review 1.  Mammalian cytosine methylation at a glance.

Authors:  Steen K T Ooi; Anne H O'Donnell; Timothy H Bestor
Journal:  J Cell Sci       Date:  2009-08-15       Impact factor: 5.285

2.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Authors:  Jacques Ferlay; Hai-Rim Shin; Freddie Bray; David Forman; Colin Mathers; Donald Maxwell Parkin
Journal:  Int J Cancer       Date:  2010-12-15       Impact factor: 7.396

3.  Dnmt1 and Dnmt3a maintain DNA methylation and regulate synaptic function in adult forebrain neurons.

Authors:  Jian Feng; Yu Zhou; Susan L Campbell; Thuc Le; En Li; J David Sweatt; Alcino J Silva; Guoping Fan
Journal:  Nat Neurosci       Date:  2010-03-14       Impact factor: 24.884

Review 4.  The epigenomics of cancer.

Authors:  Peter A Jones; Stephen B Baylin
Journal:  Cell       Date:  2007-02-23       Impact factor: 41.582

5.  A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer.

Authors:  Hongbing Shen; Luo Wang; Margaret R Spitz; Waun K Hong; Li Mao; Qingyi Wei
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

6.  Elevated Dnmt3a activity promotes polyposis in Apc(Min) mice by relaxing extracellular restraints on Wnt signaling.

Authors:  Michael S Samuel; Hiromu Suzuki; Michael Buchert; Tracy L Putoczki; Niall C Tebbutt; Therése Lundgren-May; Aliki Christou; Melissa Inglese; Minoru Toyota; Joan K Heath; Robyn L Ward; Paul M Waring; Matthias Ernst
Journal:  Gastroenterology       Date:  2009-05-18       Impact factor: 22.682

Review 7.  Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?

Authors:  Stephen B Baylin; Joyce E Ohm
Journal:  Nat Rev Cancer       Date:  2006-02       Impact factor: 60.716

8.  Dnmt3a-dependent nonpromoter DNA methylation facilitates transcription of neurogenic genes.

Authors:  Hao Wu; Volkan Coskun; Jifang Tao; Wei Xie; Weihong Ge; Kazuaki Yoshikawa; En Li; Yi Zhang; Yi Eve Sun
Journal:  Science       Date:  2010-07-23       Impact factor: 47.728

9.  DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.

Authors:  J Devon Roll; Ashley G Rivenbark; Wendell D Jones; William B Coleman
Journal:  Mol Cancer       Date:  2008-01-25       Impact factor: 27.401

10.  The DNMT3B C-->T promoter polymorphism and risk of breast cancer in a British population: a case-control study.

Authors:  Karen G Montgomery; Mira C P Liu; Diana M Eccles; Ian G Campbell
Journal:  Breast Cancer Res       Date:  2004-05-19       Impact factor: 6.466

View more
  8 in total

1.  MTHFR C677T polymorphism contributes to the risk for gastric cancer.

Authors:  Shushan Yan; Donghua Xu; Pingping Wang; Ping Wang; Chengcheng Liu; Changjiang Hua; Tao Jiang; Bin Zhang; Zengcai Li; Lei Lu; Xianzhong Liu; Bingji Wang; Donghua Zhang; Rongsheng Zhang; Shaoheng He; Beicheng Sun; Xuan Wang
Journal:  Tumour Biol       Date:  2014-03

2.  Common genetic variants in epigenetic machinery genes and risk of upper gastrointestinal cancers.

Authors:  Hyuna Sung; Howard H Yang; Han Zhang; Qi Yang; Nan Hu; Ze-Zhong Tang; Hua Su; Lemin Wang; Chaoyu Wang; Ti Ding; Jin-Hu Fan; You-Lin Qiao; William Wheeler; Carol Giffen; Laurie Burdett; Zhaoming Wang; Maxwell P Lee; Stephen J Chanock; Sanford M Dawsey; Neal D Freedman; Christian C Abnet; Alisa M Goldstein; Kai Yu; Philip R Taylor; Paula L Hyland
Journal:  Int J Epidemiol       Date:  2015-04-27       Impact factor: 7.196

3.  DNA methyltransferase 3a rs1550117 genetic polymorphism predicts poor survival in gastric cancer patients.

Authors:  Chuan Wang; Zhifang Jia; Hongxi Ma; Donghui Cao; Xing Wu; Simin Wen; Lili You; Xueyuan Cao; Jing Jiang
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

4.  Genetic polymorphism in DNMTs and gastric cancer: A systematic review and meta-analysis.

Authors:  Marco Neves; Joana Ribeiro; Rui Medeiros; Hugo Sousa
Journal:  Porto Biomed J       Date:  2016-11-21

5.  Current status and development trends of morbidity and mortality in gastric cancer patients in Xining, 2009-2016.

Authors:  Ji Di; Hejing Ji; Faxiang Ji; Junhui Zhao; Chengwu Zhang; Haixia Tang; Erchen Li; Hailan Cao; Bo Jiang
Journal:  Am J Transl Res       Date:  2021-11-15       Impact factor: 4.060

Review 6.  DNMT1, DNMT3A and DNMT3B Polymorphisms Associated With Gastric Cancer Risk: A Systematic Review and Meta-analysis.

Authors:  Hongjia Li; Wen Li; Shanshan Liu; Shaoqi Zong; Weibing Wang; Jianlin Ren; Qi Li; Fenggang Hou; Qi Shi
Journal:  EBioMedicine       Date:  2016-10-19       Impact factor: 8.143

7.  A novel functional TagSNP Rs7560488 in the DNMT3A1 promoter is associated with susceptibility to gastric cancer by modulating promoter activity.

Authors:  Huazhang Wu; Kun Zhang; Pihai Gong; Fengchang Qiao; Ling Wang; He Cui; Xinyuan Sui; Jifan Gao; Hong Fan
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

8.  Evaluation of DNMT3A genetic polymorphisms as outcome predictors in AML patients.

Authors:  Xiao-Qing Yuan; Dao-Yu Zhang; Han Yan; Yong-Long Yang; Ke-Wei Zhu; Yan-Hong Chen; Xi Li; Ji-Ye Yin; Xiao-Lin Li; Hui Zeng; Xiao-Ping Chen
Journal:  Oncotarget       Date:  2016-09-13
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.